Eton Pharmaceuticals Inc
Eton Pharmaceuticals Inc (ETON) Unusual Options Activity Today
ETON options volume power reached 1x on the previous trading day. The highest reading was on the $85 CALL expiring 2027-02-19.
Read more
Checking ETON unusual options activity helps you spot when traders are making outsized bets on Eton Pharmaceuticals Inc before the broader market catches on. Eton Pharmaceuticals Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ETON unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ETON unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ETON unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ETON unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.
It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Catalysts rarely arrive without a footprint, and ETON unusual options activity is often where that footprint shows up first. Our scanner tracks Eton Pharmaceuticals Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ETON unusual options volume on the call side or chasing put sweeps, Eton Pharmaceuticals Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 70.00 | 0.30 | 0.75 | 0.53 | 65% | 18 | 48 | 37.50% |
| 55.00 | 3.70 | 6.90 | 5.30 | 70% | 5 | 54 | 9.26% |
| 65.00 | — | 3.10 | 3.10 | 104% | 3 | 51 | 5.88% |
| 60.00 | 1.00 | 4.30 | 2.65 | 65% | 9 | 273 | 3.30% |
| 35.00 | 20.90 | 25.00 | 22.95 | 118% | 0 | 0 | — |
| 55.00 | 0.95 | 3.90 | 2.43 | 69% | 2 | 5 | 40.00% |
| 60.00 | 3.00 | 5.90 | 4.45 | 58% | 2 | 7 | 28.57% |
| 35.00 | — | 2.20 | 2.20 | 225% | 0 | 0 | — |
| 40.00 | — | 2.25 | 2.25 | 182% | 0 | 4 | 0.00% |
| 45.00 | 0.05 | 0.50 | 0.28 | 72% | 0 | 4 | 0.00% |
As of September 29, 2026
Spot unusual options activity before it moves
Track ETON options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→